Fibrinogen concentrate: Clinical reality and cautious Cochrane recommendation

British Journal of Anaesthesia

Volumn 112, Issue 5, 2014, Pages 784-787

  Kozek Langenecker, S ^a   Fries, D ^b   Spahn, D R ^c   Zacharowski, K ^d  

^a Evangelical Hospital   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PLACEBO; COAGULATING AGENT;

BLEEDING; BLOOD BANK; BLOOD COMPATIBILITY; BLOOD TRANSFUSION; COCHRANE LIBRARY; CRYOPRECIPITATE; FIBRINOGEN DEFECT; HUMAN; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW; EDITORIAL;

COAGULANTS; FIBRINOGEN; HEMORRHAGE; HUMANS;

EID: 84899804990     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu004     Document Type: Editorial

References (32)

1. Wikkelso A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev 2013; 8: CD008864
2. Rahe-Meyer N, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118: 40-50
3. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802
4. Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating lowthrombogenic potential of fibrinogen concentrate( HaemocomplettanP).BloodCoagulFibrinolysis2009;20:535-40
5. Solomon C, Hagl C, Rahe-Meyer N. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth 2013; 110: 947-56
6. Stanworth SJ, Hunt BJ. The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Crit Care 2011; 15: 1006
7. Kozek-Langenecker S, Sorensen B, Hess J, Spahn DR. Emotional or evidence-based medicine-isthereamoral tragedyinhaemostatic therapy? Crit Care 2011; 15: 462
8. Levy JH,Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion Advance Access published on Oct 9, 2013, doi: 10.1111/trf.12431
9. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76
10. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382
11. Gollop ND, Chilcott J, Benton A, et al. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus Med 2012; 22: 350-5
12. Murad MH, Stubbs JR, Gandhi MJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010; 50: 1370-83
13. Yang L, Stanworth S, Hopewell S, Doree C, MurphyM. Is fresh-frozen plasmaclinically effective?Anupdate of a systematic reviewof randomized controlled trials. Transfusion 2012; 52: 1673-86; quiz
14. Inaba K, Branco BC, Rhee P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210: 957-65
15. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-43
16. Bevan DH. Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 1999; 104: 208-19
17. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage-an observational study. Transfus Med 2012; 22: 344-9
18. World Health Organization (WHO). 63rd World Health Assembly. Availability, safety and quality of blood products. 2010. Available from http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-R12-en .pdf (accessed 22 October 2013)
19. Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth 2012; 109: 135-7
20. Ranucci M. Fibrinogen supplementation in cardiac surgery: where are we now and where are we going? J Cardiothorac Vasc Anesth 2013; 27: 1-4
21. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47
22. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation managementof major traumapatients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55
23. Hiippala ST, Myllyla GJ,VahteraEM.Hemostatic factorsandreplacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5
24. Goodnough LT, Spain DA, Maggio P. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol 2013; 26: 208-14
25. Goodnough LT, Shander A. How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. Blood 2011; 117: 6091-9
26. Octapharma. Octaplas summary of product characteristics. Available from http://www.octapharma.co.uk/index.php?eID=tx- nawsecuredl&u=0&file= uploads/media/octaplasLG-SmPC-01.pdf& t=1393419280&hash= ddc2b6fbb6e096a0a733896dc09c0f220a7e e262 (accessed 25 February 2014)
27. Cote CJ, Drop LJ, Hoaglin DC, Daniels AL, Young ET. Ionized hypocalcemiaafter freshfrozenplasmaadministration to thermally injured children: effects of infusion rate, duration, and treatment with calcium chloride. Anesth Analg 1988; 67: 152-60
28. Theusinger OM, BauligW, Seifert B, et al. Relative concentrations of haemostatic factors and cytokines in solvent/detergenttreated and fresh-frozen plasma. Br J Anaesth 2011; 106: 505-11
29. Solomon C, Pichlmaier U, Schoechl H, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104: 555-62
30. Danish Medicine Agency. Medicine prices in Denmark. Available from http://www.medicinpriser.dk/(accessed 29 October 2013)
31. ShanderA, HofmannA,Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65
32. Glenngard AH, Persson U, Soderman C. Costs associated with blood transfusions in Sweden-the societal cost of autologous, allogeneic and perioperative RBC transfusion. Transfus Med 2005; 15: 295-306